Results 101 to 110 of about 33,898 (194)

Impact of Symptoms of Neuromyelitis Optica Spectrum Disorder and Patient‐Determined Oral Glucocorticoid–Related Adverse Events on Patients' Daily Living and Emotions: A Qualitative Analysis From Japan

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Background and Objectives Neuromyelitis optica spectrum disorder (NMOSD) is a chronic disorder with a relapsing–remitting disease course that impacts patients' quality of life. Oral glucocorticoids (OGCs) have been the standard of care for NMOSD in Japan; however, their chronic use is associated with adverse events (AEs).
Yuko Shimizu   +7 more
wiley   +1 more source

New Insights into Neuromyelitis Optica [PDF]

open access: diamond, 2011
Woojun Kim, Su‐Hyun Kim, Ho Jin Kim
openalex   +1 more source

Assessing the Benefits of “Circle”: A Patient Support Program for Neuromyelitis Optica Spectrum Disorder for Patients Receiving Satralizumab Treatment

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objectives Although satralizumab, an interleukin‐6 receptor inhibitor, effectively prevents relapses in neuromyelitis optica spectrum disorder (NMOSD), infections are reported to be the most common adverse reactions. To support Japanese patients receiving satralizumab, “Circle”—a 1‐year patient support program—was developed.
Kazuo Fujihara   +3 more
wiley   +1 more source

Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas   +3 more
wiley   +1 more source

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4‐IgG+ NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
In this multicenter cohort study, we evaluated the risk of infection in people with AQP4‐IgG+ NMOSD treated with rituximab. We found no significant difference in infection risk between patients receiving rituximab and those treated with azathioprine.
Daniel Engels   +29 more
wiley   +1 more source

Optical Sensing Using Hybrid Multilayer Grating Metasurfaces with Customized Spectral Response

open access: yesSensors
Customized metasurfaces allow for controlling optical responses in photonic and optoelectronic devices over a broad band. For sensing applications, the spectral response of an optical device can be narrowed to a few nanometers, which enhances its ...
Mahmoud H. Elshorbagy   +2 more
doaj   +1 more source

Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI [PDF]

open access: bronze, 2016
Sanjeev Chawla   +9 more
openalex   +1 more source

Community‐driven variations in snow algae color modulate snow albedo reduction

open access: yesNew Phytologist, Volume 249, Issue 4, Page 1739-1752, February 2026.
Summary Snow algae blooms visibly alter snow color and surface energy balance, yet the biological basis of this variability remains unclear. We investigated how pigment composition and community structure shape the optical properties of snow algae blooms of distinct colors – red, orange, and green – co‐occurring within the same snowfield in Glacier ...
Pablo Almela   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy